Anpario (LON:ANP) Posts Earnings Results

Anpario (LON:ANP) released its quarterly earnings data on Wednesday. The company reported GBX 22.45 EPS for the quarter, Digital Look Earnings reports. Anpario had a return on equity of 17.05% and a net margin of 14.53%.

Anpario Stock Performance

Shares of ANP stock traded down GBX 12.50 on Friday, hitting GBX 460. The company’s stock had a trading volume of 43,166 shares, compared to its average volume of 45,453. Anpario has a fifty-two week low of GBX 391.11 and a fifty-two week high of GBX 580. The company has a market capitalization of £74.92 million, a PE ratio of 12.12 and a beta of 1.08. The stock’s 50 day moving average is GBX 529.75 and its 200-day moving average is GBX 516.08. The company has a debt-to-equity ratio of 0.60, a quick ratio of 5.16 and a current ratio of 6.29.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Shore Capital Group reaffirmed a “house stock” rating on shares of Anpario in a research report on Monday, August 17th. Canaccord Genuity Group raised their target price on shares of Anpario from GBX 570 to GBX 600 and gave the company a “buy” rating in a research note on Friday. One equities research analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, Anpario currently has an average rating of “Buy” and an average target price of GBX 600.

Anpario Company Profile

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.